Esomeprazole and omeprazole may possibly boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) resulting in enhanced adverse effects for example drowsiness, although the medical relevance is reduced for most sufferers – monitor the client for adverse effects (e.If patient are not able to resume their regular oral medi